MTOR and age-related macular degeneration: It has been published, that process of pathological angiogenesis includes activation of mTOR pathway selectively in proliferative state endothelial cells (ECs) and mTOR inhibitors target these cells [15], suggesting that mTOR is a potential target for the treatment of wet-AMD.